(Circulation. 1998;98:2891-2898.)
© 1998 American Heart Association, Inc.
Basic Science Reports |
From the Department of Internal Medicine III, Kurume University School of Medicine (A.K., H. Ikeda, T.M., N.H., T.I.), and the Third Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co (H. Ito), Japan.
Correspondence to Hisao Ikeda, MD, Department of Internal Medicine III, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830, Japan. E-mail ikeikeda{at}med.kurume-u.ac.jp
BackgroundIn the thrombotic process of acute coronary syndromes, the pathophysiological role of thromboxane A2 via cyclooxygenase is well established; however, the role of 12-HETE via 12-lipoxygenase is little known. Therefore, we used OPC-29030, a novel specific inhibitor of 12-HETE synthesis, to test whether platelet-derived 12-HETE is involved in mediating cyclic flow variations (CFVs) and platelet aggregation in stenosed and endothelium-injured canine coronary arteries.
Methods and ResultsAfter developing CFVs, dogs received a vehicle or OPC-29030 intravenously. Plasma and intraplatelet 12-HETE levels increased after CFVs. OPC-29030 but not vehicle reduced CFVs, which was associated with decreases in plasma and intraplatelet 12-HETE levels. Cessation of OPC-29030 restored CFVs in association with increases in plasma and intraplatelet 12-HETE levels. ADP and U46619 induced ex vivo platelet 12-HETE production and aggregation. After OPC-29030 administration, the ADP- and U46619-induced increases in ex vivo platelet 12-HETE production and aggregation were inhibited significantly. Platelet aggregation was linearly correlated with platelet 12-HETE production. OPC-29030 suppressed activation of human platelet glycoprotein IIb/IIIa.
ConclusionsOPC-29030 reduced intraplatelet 12-HETE levels, resulting in the inhibition of coronary thrombosis in vivo in dogs. OPC-29030 inhibited human platelet glycoprotein IIb/IIIa activation in vitro. Thus, platelet-derived 12-HETE may play an important role in mediating thrombotic process.
Key Words: platelets hydroxyeicosatetraenoic acid platelet aggregation glycoproteins thrombosis
This article has been cited by other articles:
![]() |
K. Tanriverdi and J. E. Freedman Blood and Cardiovascular Disease: The Promise and Limitations of Gene Expression Analysis Circ Cardiovasc Genet, October 1, 2008; 1(1): 7 - 9. [Full Text] [PDF] |
||||
![]() |
S. Yokoyama, H. Ikeda, N. Haramaki, H. Yasukawa, T. Murohara, and T. Imaizumi Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1280 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kanaya, H. Ikeda, N. Haramaki, T. Murohara, and T. Imaizumi Intraplatelet Tetrahydrobiopterin Plays an Important Role in Regulating Canine Coronary Arterial Thrombosis by Modulating Intraplatelet Nitric Oxide and Superoxide Generation Circulation, November 13, 2001; 104(20): 2478 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nie, K. Tang, C. Diglio, and K. V. Honn Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase Blood, April 1, 2000; 95(7): 2304 - 2311. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |